Teachers Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Teachers Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.69M	Buy	107,067 +45,493	+74%	+$789K	﹤0.01%	2052
2018 Q4	$1.24M	Sell	61,574 -1,328	-2%	-$29.3K	﹤0.01%	2092
2018 Q3	$1.56M	Buy	62,902 +2,741	+5%	+$74.5K	﹤0.01%	2096
2018 Q2	$1.65M	Buy	60,161 +8,789	+17%	+$264K	﹤0.01%	2063
2018 Q1	$1.58M	Buy	51,372 +8,837	+21%	+$284K	﹤0.01%	1972
2017 Q4	$1.52M	Buy	42,535 +1,620	+4%	+$46.5K	﹤0.01%	2020
2017 Q3	$1.13M	Buy	40,915 +33	+0.1%	+$800	﹤0.01%	2166
2017 Q2	$1.08M	Buy	40,882 +7,184	+21%	+$160K	﹤0.01%	2185
2017 Q1	$701K	Sell	33,698 -24	-0.1%	-$493	﹤0.01%	2360
2016 Q4	$698K	Buy	33,722 +1,650	+5%	+$27.6K	﹤0.01%	2367
2016 Q3	$520K	Hold	32,072	–	–	﹤0.01%	2448
2016 Q2	$436K	Buy	32,072 +2,322	+8%	+$41.1K	﹤0.01%	2493
2016 Q1	$519K	Buy	29,750 +3,610	+14%	+$73.5K	﹤0.01%	2322
2015 Q4	$893K	Buy	26,140 +3,243	+14%	+$112K	﹤0.01%	2066
2015 Q3	$681K	Hold	22,897	–	–	﹤0.01%	2205
2015 Q2	$732K	Buy	22,897 +10,902	+91%	+$280K	﹤0.01%	2298
2015 Q1	$249K	Buy	11,995 +1,471	+14%	+$25.4K	﹤0.01%	2797
2014 Q4	$178K	Hold	10,524	–	–	﹤0.01%	2942
2014 Q3	$203K	Hold	10,524	–	–	﹤0.01%	2878
2014 Q2	$358K	Sell	10,524 -156	-1%	-$4.89K	﹤0.01%	2635
2014 Q1	$336K	Buy	+10,680	New	+$334K	﹤0.01%	2608

Other funds holding RVNC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Teachers Advisors's RVNC Position: Q1 2019 in Review

Teachers Advisors increased its Revance Therapeutics, Inc. (RVNC) stake by 74% in Q1 2019, buying an estimated $789K and bringing the position to 107,067 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Teachers Advisors first reported a position in RVNC in Q1 2014 and has held it in 21 quarters since. 112 funds tracked by Wall St. Rank hold RVNC as of Q1 2019.

Teachers Advisors held 107,067 shares of Revance Therapeutics, Inc. worth $1.69M as of Q1 2019.
Teachers Advisors bought 45,493 Revance Therapeutics, Inc. shares in Q1 2019, an estimated $789K.
Revance Therapeutics, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2052 holding.
Teachers Advisors first reported a position in Revance Therapeutics, Inc. in Q1 2014 and has held it in 21 quarters since.
112 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.